Advertisement

Topics

AstraZeneca Earnings Fall Amid Patent Protection Losses

08:31 EST 9 Nov 2017 | Pharmaceutical Processing

This article has expired, however you can still download the PDF.
Preview:
NewsAstraZeneca has been dealing with the loss of exclusivity on previous moneymakers like the cholesterol treatment Crestor and schizophrenia treatment Seroquel XR.Contributed Author: Associated PressTopics: Big Pharma...

Other Sources for this Article

Original Article: AstraZeneca Earnings Fall Amid Patent Protection Losses

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca Earnings Fall Amid Patent Protection Losses"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...